Revenue Breakdown
Composition ()
No data
Revenue Streams
Profitability & Margins
Evaluating the bottom line, Ascentage Pharma Group International maintains a gross margin of 90.74%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -252.00%, while the net margin is -252.81%. These profitability ratios, combined with a Return on Equity (ROE) of -161.85%, provide a clear picture of how effectively AAPG converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, AAPG competes directly with industry leaders such as ASND and JAZZ. With a market capitalization of $1.96B, it holds a significant position in the sector. When comparing efficiency, AAPG's gross margin of 90.74% stands against ASND's 92.90% and JAZZ's 71.34%. Such benchmarking helps identify whether Ascentage Pharma Group International is trading at a premium or discount relative to its financial performance.
